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ABSTRACT
CHARACTERIZING THE MECHANISMS OF
INSULIN RESISTANCE IN DAIRY CATTLE
Amanda N. Davis
Dairy cows transitioning from gestation to lactation experience insulin resistance as maternal
adaptation to partition nutrients toward the mammary gland to support milk production. Insulin
resistance causes increased lipolysis and free fatty acid (FFA) release into circulation.
Unfortunately, this metabolic adaptation occurs during a time when energy demands are
heightened and cows are already experiencing negative energy balance. As a result, accelerated
hepatic FFA influx promotes hepatic triacylglycerol (TAG) accumulation and ketogenesis, which
can cause postpartum metabolic disease. In diabetic monogastrics, mechanisms that mediate
insulin resistance involve the sphingolipid ceramide. The role of ceramide in insulin signaling in
dairy cows transitioning from gestation to lactation has not been previously established. The
studies presented in this master of science thesis evaluate the relationship between fatty acid
availability, ceramide synthesis, and insulin sensitivity. In the first experiment, we tested the
hypothesis that ceramide accumulates in dairy cows experiencing lipolysis and insulin resistance.
We show that nutrient restriction (NR) increased serum fatty acids and ceramide levels, and
impaired insulin sensitivity; however, infusion with nicotinic acid (NA), a known suppressor of
lipolysis, was unable to prevent these responses. We also showed that NR increased hepatic
ceramide accumulation, a response that was positively associated with serum ceramide supply.
Our data demonstrate that circulating and hepatic 24:0-Cer are inversely associated with
systemic insulin tolerance, an effect not observed for the 16:0 moiety. In the second experiment,
our objective was to characterize relationship between prepartum adiposity and insulin
sensitivity in dairy cows transitioning from gestation to lactation. Our data demonstrate that
during the periparturient period, FFA, BHBA, and liver lipid increase, more so for overweight
cows. While plasma glucose and serum insulin were not affected by adiposity, serum insulin
concentrations decreased postpartum. Using a hyperinsulinemic-euglycemic clamp (HEC)
technique to directly measure insulin sensitivity, we show that steady state serum glucose,
insulin, and FFA levels were not modified by adiposity. HEC glucose infusion rate was not
affected by adiposity, but systemic insulin resistance developed in overweight cows postpartum
when accounting for changes in insulin and glucose. Insulin-stimulated phosphorylation of
subcutaneous adipose tissue AKT was not modified by adiposity, but AKT phosphorylation
significantly decreased from pre- to postpartum. Collectively, these data demonstrate that
adiposity does not affect adipose tissue-specific insulin signaling, even though it did impair
insulin sensitivity as indicated by the SIClamp.
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Chapter 1
INTRODUCTION
Due to intense genetic selection, milk production per cow has risen dramatically over the
last century, with cows producing 20,000 kg of milk per lactation (Oltenacu and Broom, 2010).
This dramatic increase in milk production has been accompanied by a decrease in fertility, an
increase in the incidence of metabolic disease, and a decrease in longevity of the cow (Oltenacu
and Broom, 2010). Specifically, these detrimental consequences can be attributed to the
metabolically challenging transition from gestation to lactation. During the peripartum, the dairy
cow experiences a coordinated shift in metabolism to divert energy away from maternal
utilization, and toward the mammary gland to support copious milk production (Bell and
Bauman, 1997). Unfortunately, the periparturient cow cannot meet the energy demands of
lactation and in turn the animal relies extensively on catabolism to meet energy requirements
(Bauman and Currie, 1980).
The pancreatic hormone insulin plays a fundamental role in regulating metabolic changes
that develop during the peripartum. Resistance by peripheral tissues to the insulin signal
facilitates partitioning of nutrients (e.g., glucose and fatty acids) to the mammary gland to
support milk synthesis (Hart, 1983). Because insulin is an anti-lipolytic hormone, insulin
resistance can lead to mobilization of adipose triacylglycerol (TAG) reserves as an adaptation to
meet energy demand. Moreover, reduction in glucose uptake by skeletal muscle and adipose
tissue spares glucose for mammary lactose synthesis (Bauman and Currie, 1980; Bell, 1995; Bell
and Bauman, 1997). The magnitude of insulin resistance may be heightened by adiposity (Zachut
et al., 2013). Overconditioned cows experience exacerbated lipolysis during the peripartum,
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which can increase risk of developing a metabolic disease (i.e., fatty liver or ketosis) and
negatively impact reproductive success.
Characterizing mechanisms of insulin resistance during energy deficit or in cows with
enhanced peripartal adiposity is needed to develop practical nutrition and management practices
to control insulin action and maximize cow health. In diabetic monogastrics with non-alcoholic
fatty liver disease, mechanisms of insulin resistance involve the sphingolipid ceramide (Holland
and Summers, 2008). Ceramide represents a lipid mediator that reduces insulin sensitivity in part
by inhibiting activation of protein kinase B (AKT) within the insulin signaling cascade (Powell
et al., 2003; Hajduch et al., 2008). Although previous work has demonstrated that hepatic and
circulating ceramide increases during the transition from gestation to lactation in cows (Rico et
al., 2015; Rico et al., 2016; Mathews et al., 2016), the effects of energy deficit on ceramide
accrual remained undefined in dairy cattle; therefore, the hypotheses of these studies were that
hepatic and circulating ceramide increases in association with controlled feed-restriction and
insulin antagonism and that prepartum adiposity reduces systemic and localized insulin
sensitivity via AKT-dependent mechanisms.
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Chapter 2
LITERATURE REVIEW
Energy Metabolism in Dairy Cows
Dairy cows transitioning from gestation to lactation are challenged by increased energy
requirements for fetal growth and milk production during a time when energy intake is
suppressed. Onset of energy deficit begins three weeks prior to parturition, and as parturition
approaches, maternal dry matter intake (DMI) decreases by 10 to 30% (Bell, 1995). Immediately
following parturition, net energy for lactation (NEL) and metabolizable protein required for milk
production exceeds intake by 26 and 25%, respectively (Bell, 1995). Considering that the
mammary gland uses 97 and 83% of the consumed NEL and metabolizable protein, respectively
(Bell, 1995), energy deficit can have detrimental consequences on milk synthesis. Because the
peripartal cow experiences high nutrient demand, a physiological state of negative energy
balance (NEB) develops. To meet the heightened demand for energy, the cow will mobilize
energy stores including triacylglycerol (TAG), protein, and glycogen. As lactation advances,
intake is restored, energy balance improves, and energy stores are repleted.
The onset of lactation is characterized by homeorhetic adaptations that facilitate the
partitioning of nutrients away from maternal utilization and toward the mammary gland for milk
component synthesis. First, the mammary gland uses glucose for synthesis of lactose, the major
osmotic regulator of milk volume. To ensure adequate glucose delivery to the mammary gland,
hepatic gluconeogenesis increases (Reynolds et al., 2003) and oxidation of glucose by peripheral
tissues decreases (Bennink et al., 1972). Substrates for gluconeogenesis include propionate from
microbial fermentation in the rumen, lactate from the Cori cycle, amino acids (AA; e.g. alanine)
from protein catabolism, and glycerol mobilized from adipose tissue TAG (Seal and Reynolds,
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1993). The cow relies predominantly on propionate as a substrate for gluconeogenesis; however
the contribution from glycerol increases during energy deficit and associated adipose tissue
mobilization (Lomax et al., 1983; Aschenbach et al., 2010). Furthermore, peripartal glucose
uptake by skeletal muscle and adipose tissue is decreased because of the development of
localized insulin resistance, thereby facilitating glucose uptake by the mammary gland in an
insulin-independent manner (Bell and Bauman, 1997; De Koster and Opsomer, 2013).
Development of insulin resistance also partitions free fatty acids (FFA) to the mammary gland
for their re-esterification into milk fat TAG. (McNamara and Hillers, 1986; Zachut et al., 2013).
Noticeable increases in milk fat yields and content are observed immediately postpartum,
relative to mid or late lactation. Additionally, circulating FFA are used for β-oxidation in
peripheral tissues and hepatic ketogenesis. Beyond peak milk production, insulin sensitivity in
peripheral tissues is restored to partition glucose toward skeletal muscle and adipose tissue, and
away from the mammary gland (McNamara and Hillers, 1986; Bell and Bauman, 1997). As a
consequence, nutrients are diverted towards body tissue accretion and the developing fetus as
positive energy balance is reestablished.
Metabolic Disease
In dairy cows, negative energy balance can promote the development of metabolic
disease during the peripartum. A hallmark characteristic of metabolic impairment is
accumulation of fat in liver tissue (i.e., fatty liver disease). Although FFA can be oxidized in
liver, fatty liver develops because of increased FFA esterification in response to elevated FFA
uptake (Pullen et al., 1989; Reynolds et al., 2003). Moreover, hepatic TAG export within very
low density lipoprotein (VLDL) is much lower in ruminants compared to nonruminants (Pullen
et al., 1990). Therefore, when the rate of hepatic FFA influx exceeds the rate of oxidation and
4

export during the peripartum, liver lipid accumulation ensues (Hocquette and Bauchart, 1999).
The low secretion of VLDL from the liver may be due to limited availability of VLDL
components (Bauchart et al., 1996). Such components may include apolipoproteins, cholesterol,
or phosphatidylcholines (Bernabucci et al., 2004; Loor et al., 2007; Kessler et al., 2014).
In addition to hepatic TAG accumulation, excessive oxidation of fatty acids can
contribute to rampant ketogenesis (i.e., the production of acetoacetate, acetone, and βhydroxybutyrate (BHBA) from acetyl-CoA). In turn, elevated levels of ketones promote clinical
and subclinical ketosis (Esposito et al., 2014). Furthermore, fatty liver disease can interfere with
hepatic gluconeogenesis by limiting transformation of propionate to glucose in part by inhibiting
the vitamin B12-dependent enzyme methylmalonyl-coA mutase (Piepenbrink and Overton,
2003b; McDowell, 2000; Preynat et al., 2010). Fatty liver disease and ketosis are linked with
immunosuppression, which is likely a cause of retained placenta (Ingvartsen et al., 2003) and
environmental mastitis (Mallard et al., 1998). Moreover, cows that experience retained placenta
often develop metritis and become infertile (Coleman et al., 1985). Other disorders associated
with NEB and poor hepatic health include displacement of the abomasum, metritis, and milk
fever (Le Blanc et al., 2005a, b). Collectively, the onset of these metabolic diseases can
compromise milk production and fertility that can result in enhanced veterinary costs and culling
rates (Wathes et al., 2007). Therefore, novel nutritional strategies are needed to improve bovine
energy status and hepatic health during the peripartum.
Dietary approaches to mitigate disease
Pregnant cows fed in nutrient excess are susceptible to body fat accumulation (Morrow,
1976; Roche et al., 2013), which can cause a more severe decrease in DMI around calving
thereby contributing to excessive adipose tissue lipolysis (Rico et al., 2015; Holtenius et al.,

5

2003; Holtenius et al., 2007). Lean cows [body condition score (BCS) of 2-2.5; Wildman et al.,
1982] tend to have higher DMI and milk yield postpartum than cows with excessive adiposity
(BCS of 3.5 to 4; Garnsworthy and Topps 1982a, 1982b; Treacher et al., 1986; Garnsworthy and
Jones, 1987). Moreover, an elevated calving and early lactation BCS are associated with an
increased incidence of ketosis (Gillund et al., 2001), milk fever (Roche and Berry, 2006), and
fatty liver (Drackley, 1999). Cows that exhibit a greater BCS loss during the early postpartum (≥
1.25 points) are half as likely to conceive at first insemination and thus have a longer calving to
conception interval (Gillund et al., 2001). Considering this evidence, dairy producers are
encouraged to manage cattle to achieve a BCS of 3.0 to 3.25 at dry off (~40 to 60 d prepartum;
Contreras et al., 2004; Gillund et al., 2001).
Controlling prepartum adiposity can be achieved by limiting dietary energy intake.
Douglas and colleagues (2006) fed moderate grain- or fat-supplemented diets (1.50 Mcal of
NEL/kg) from dry off (60 days before expected parturition) to calving at either ad libitum (160%
of NEL requirement) or restricted (80% of NEL requirement) intakes. During the first 21 days in
milk, cows previously energy-restricted had higher intakes of DMI and NEL. Relative to ad
libitum feeding, nutrient restriction reduced plasma concentrations of FFA and BHBA, and liver
concentrations of total lipid and TAG postpartum. In support of this work, Dann and coworkers
(2006) found similar metabolite responses postpartum when comparing a high plane (150% of
NRC energy requirements) versus a low plane of nutrition (80 or 100% or NRC requirements)
during the early dry period (from dry-off to -25 d relative to expected parturition). Interestingly,
plane of nutrition during the close-up period (three weeks prepartum) did not affect these
parameters postpartum (Dann et al., 2006). Moreover, Mann and coworkers (2015) examined the
effects of feeding a high fiber, controlled-energy diet for the dry period duration (100% of
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energy requirements; starting 57 days before expected parturition) versus a high-non-fiber
carbohydrate (NFC), high-energy- diet (150% of energy requirements). A third treatment group
received the high energy diet for the first 28 days after dry off followed by an intermediate diet
containing 125% of energy requirements until calving. They found that cows fed a high plane of
nutrition had higher circulating BHBA and FFA, and more severe NEB postpartum. The
controlled-energy diet improved energy balance as well as lowered the frequency and severity of
hyperketonemia postpartum. More so, switching from a high-energy diet to an intermediateenergy diet during the close-up period did not completely ameliorate negative effects of feeding
a high-energy diet for the duration of the dry period.
Although restricting energy for the entire dry period appears to benefit cow health and
milk production, some evidence supports feeding a higher energy diet for two to three weeks
before calving (Mashek and Beede, 2001; Corbett, 2002; Contreras et al., 2004), a response that
is likely due to the source of dietary carbohydrate (CHO) fed. Specifically, the concentration of
non-fiber CHO (NFC; e.g., highly digestible sugars and starch) and neutral detergent fiber (NDF;
e.g., cellulose, hemicellulose, and lignin) can influence microbial fermentation and volatile fatty
acid production. Volatile fatty acids (e.g., propionate, butyrate, and acetate) are essential energy
sources derived from rumen microbial fermentation of CHO (Bergman, 1990; Nafikov and Beitz,
2007). Undoubtedly, energy density of the postpartum diet must be increased to meet the demand
of lactation. However, a sudden increase in dietary energy density from highly fermentable NFC
may lead to subacute ruminal acidosis due to lactate accumulation, which can decrease DMI,
contribute to NEB and thus FFA mobilization and hepatic lipid deposition (Ingvartsen et al.,
2006; Mulligan and Doherty, 2008). Using close-up diets containing increased levels of starch
has been suggested to allow the rumen to adapt to a high-grain diet before the onset of lactation.
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A number of studies have reported positive effects on metabolism postpartum after feeding a
higher concentration of NFC prepartum (reviewed by Overton and Waldron, 2004). For example,
Minor and coworkers (1998) found that cows fed a high NFC diet for 19 days before calving had
higher plasma glucose concentrations and lower FFA and BHBA concentrations, reduced liver
lipid accumulation, and higher milk production than cows fed a low NFC diet. However, it is
difficult to attribute changes in metabolic health postpartum to dietary CHO source prepartum
because most experiments examining the effects of NFC content of the prepartum diet have
confounding effects due to either energy content (Minor et al., 1998; Mashek and Beede, 2000;
Holcomb et al., 2001) or fat content (Grum et al., 1996). Smith and coworkers (2005, 2008)
examined the effects of NFC content in prepartum diets independent of dietary energy or fat
content. They offered cows one of two diets from day -21 relative to parturition until calving
containing either high NFC (40.3% of dry matter) or low NFC (33.6% of dry matter). Milk yield
and dry matter intake were not affected by prepartum NFC source (Smith et al., 2005). Cows fed
the high NFC diet tended to have lower plasma FFA concentrations postpartum. However, cows
on this diet also tended to have higher BHBA and lower liver glycogen concentrations (Smith et
al., 2008) making interpretation challenging. Collectively, feeding high-energy diets for the
entirety of the dry period has negative effects on health and milk production, and feeding a low
plane of nutrition for the dry period duration is recommended to minimize the incidence of
postpartum metabolic disease; however, more research is needed to determine the balance of
NFC and energy necessary during the closeup period to improve metabolic health during the
early postpartum.
Dietary fats may also affect metabolism and reproduction during the peripartum, and fat
supplementation represents a common practice on dairy farms. Feeding fat supplements that can
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suppress milk fat production during the early postpartum period may help to minimize NEB,
reduce adipose tissue mobilization, and improve fertility. For example, Caldari-Torres and
colleagues (2011) examined the effects of feeding diets enriched in either saturated fatty acids
(SFA), calcium (Ca) salts of trans-octadecenoic fatty acids (tFA), or Ca salts of safflower oil
fatty acids (SFL) starting 28 days before expected parturition on performance, metabolic, and
endocrine responses. Cows fed SFL produced less milk fat and entered positive energy balance
sooner after parturition than those fed tFA. Furthermore, plasma FFA concentrations were lower
in cows fed the SFL diet than in those consuming the tFA diet. Moreover, plasma glucose,
insulin-like growth factor-I (IGF-I), and progesterone were greater in animals fed the SFLenriched diet compared with those fed SFA, reflecting improved energy balance and potential
corpus luteum development. Altering the ratio of dietary n-6 to n-3 fatty acids (FA) during the
peripartum can influence the release of prostaglandin F2α (PGF2α), an eicosanoid that controls
the lifespan of the corpus luteum and might influence the retention of fetal membranes (Santos et
al., 2008). Petit and coworkers (2004) showed that feeding n-6 FA resulted in increased
circulating PGF2α following an oxytocin challenge early postpartum (Petit et al., 2004), while
feeding n-3 FA has been shown to reduce PGF2α production after an oestradiol/oxytocin
challenge (Mattos et al., 2002). Furthermore, Silvestre and colleagues (2011) examined the effect
of feeding Ca-salts of palm oil (PO; low in n-6 and n-3 FA) or safflower oil (SO; high in n-6 FA)
from 30 days prepartum to 30 days postpartum, followed by feeding Ca-salts of PO or fish oil
(high in n-3 FA) from 30 to 160 days postpartum. They found that supplementation of n-3 FA
decreased pregnancy loss from the first artificial insemination and increased second service
pregnancy per service. This effect was enhanced when cows were fed n-6-enriched diets during
the transition period. The combination of feeding n-6 FA during the transition period followed
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by feeding n-3 FA during the breeding period represented the best combination of FA
supplementation. Silvestre and coworkers (2011) suggested that n-3 FA increases the
concentrations of eicosapentaenoic and docosahexaenoic acids in the caruncular and endometrial
tissues, which competitively inhibit arachidonic acid from producing PGF2α , thus delaying
luteolysis (Mattos et al., 2000; 2003; 2004).
Collectively, current research supports that to maintain postpartum metabolic health and
milk production restriction of energy intake during the dry period is recommended to promote
DMI and improve energy balance after calving. However, the short-term application of a
moderate-starch diet immediately before expected calving can prepare the rumen for high energy
early lactation diets. Finally, feeding polyunsaturated fatty acids during the postpartum may
represent a method to improve metabolic health if compromised by energy impairments caused
by prepartum overnutrition.
Insulin Sensitivity in Dairy Cows
Insulin signaling cascade
The insulin signaling transduction pathway has been extensively studied in monogastrics
(Chavez and Summers, 2010). In the fed state, insulin stimulates uptake of glucose into insulinsensitive adipose and skeletal muscle tissues, and inhibits lipolysis (Duncan et al., 2007). The
cascade of events begins with insulin binding to its receptor. The insulin receptor consists of two
α-subunits and two β-subunits linked by disulfide bonds. The α-subunits are extracellular and
contain an insulin binding site, while the cytosolic β-subunits are adjacent to the plasma
membrane (Hedo and Simpson, 1984). When insulin binds to the α-subunit, the β-subunits
become activated by auto-phosphorylation of tyrosine residues (Kasuga et al., 1982; Ward and
Lawrence, 2009). The β-subunit then recruits the insulin receptor substrate (IRS) protein and
10

uses its tyrosine kinase activity to phosphorylate IRS on multiple tyrosine residues.
Phosphorylation of IRS signals for the recruitment and activation of phosphatidylinositol 3kinase (PI3K; Sun et al., 1993; Avruch, 1998). Phosphatidylinositol 3-kinase contains Srchomology-2 domains that bind to tyrosine-phosphorylated IRS, which then activates the catalytic
subunit of PI3K (Myers et al., 1992; Virkamäki et al., 1999; Shaw, 2011). Activation of PI3K
signals recruitment and phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) to form
phosphatidylinositol 3,4,5-triphosphate (PIP3) at the plasma membrane. These phosphoinositides
then recruit protein kinase B (AKT) to the plasma membrane, where it becomes phosphorylated
on specific threonine and serine residues by phosphoinositide-dependent kinase-1 (PDK-1) and
PDK-2, respectively (Saltiel and Kahn, 2001; Petersen and Shulman, 2006).
Protein kinase B can then mediate activation of lipogenesis, glycogen synthesis, and
glucose uptake via translocation of the only insulin sensitive glucose transporter, GLUT4, to the
plasma membrane (Bae et al., 2003), and inhibit gluconeogenesis and glycogenolysis through
activation of glycogen synthase kinase-3 (Cross et al., 1995), AKT substrate 160 (Karlsson et al.,
2005), and forkhead box protein 01 (Tzivion et al., 2011). Insulin’s anti-lipolytic effect is also
mediated by AKT. Specifically, insulin signaling activates phosphodiesterase 3B (PDE3B) via
AKT-mediated phosphorylation of serine residue 273 (Degerman et al., 1998; Kitamura et al.,
1999). When PDE3B is activated, it catalyzes hydrolysis of cyclic adenosine monophosphate
(cAMP) to 5’AMP so that protein kinase A (PKA) activity is reduced (Manganiello et al., 1996;
Degerman et al., 1997). Reduction in PKA leads to decreased activity of hormone-sensitive
lipase and reduction in TAG hydrolysis (Eriksson et al., 1995; Beebe et al., 1985; Degerman et
al., 1990).
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Mechanisms of insulin resistance
Besides insulin, other endocrine hormones such as glucagon, epinephrine, and GH play a
role in coordinating the anabolic to catabolic shift in metabolism that accompanies the transition
from gestation to lactation. First an increase in gluconeogenesis during lactation is promoted by
glucagon and catecholamines. Glucagon enhances the supply of gluconeogenic precursors by
mobilizing FFA and glycerol from adipose tissue, and catecholamines stimulate lactate
production from muscle (Hart et al., 1983). Moreover, somatotropin (growth hormone, GH) is a
known to inhibit insulin-stimulated glucose uptake and lipogenesis in adipose tissue (Bauman
and Vernon, 1993). Under normal conditions, GH increases circulating concentrations of insulinlike growth factor I (IGF-I), which inhibits further production of GH by the pituitary gland
(Bichell et al., 1992; Le Roith et al., 2001). The GH-IGF-I axis uncouples in the liver during high
nutrient demand, as during the transition to lactation (Thissen et al., 1994), resulting in decreased
IGF-I and increased GH in circulation (Taylor, 2004). Therefore, researchers hypothesized that
GH is responsible for causing insulin resistance during early lactation (Bell and Bauman, 1997).
This hypothesis was supported by the observation that chronic treatment of lactating dairy cows
with bovine somatotropin (bST) decreased insulin-dependent GLUT4 mRNA expression in
omental adipose tissue (Zhao et al., 1996). Moreover, bST administration reduced insulin
receptor concentration and tyrosine kinase activity in skeletal muscle of rapidly growing lambs
(Wilson et al., 1996), and lowered GLUT4 mRNA expression in lactating dairy cow muscle
(Zhao et al., 1996). This hypothesis was further strengthened by the observation that bST
administration had no effect on the abundance of GLUT1 mRNA, which is not insulinresponsive, in the mammary gland of lactating cows (Zhao et al., 1996).
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The transition from gestation to lactation is characterized by a dynamic change in
metabolic regulation to support fetal growth and milk synthesis, and insulin certainly plays a
major role to facilitate glucose partitioning towards the fetus and the mammary gland (Bauman
Currie, 1980). The concentration and sensitivity to insulin decreases dramatically as lactation
approaches (Bauman and Currie, 1980; Bell, 1995; Bell and Bauman, 1997). A decrease in
circulating insulin concentration in part reduces insulin-stimulated glucose uptake. Also, the
decrease in circulating insulin concentration is accompanied by a decrease in insulin sensitivity
(i.e., increased insulin resistance) as a metabolic adaptation to lactation (Bell and Bauman, 1997;
Kerestes et al., 2009). A reduction in insulin sensitivity increases hepatic gluconeogenesis and
lipolysis to meet the demands of milk production. Moreover, the relationship between NEB and
systemic insulin sensitivity is well established. For example, partial nutrient restriction or fasting
decreases insulin-stimulated glucose clearance measured with an insulin tolerance test (ITT;
Oikawa and Oetzel, 2006) or glucose tolerance test (GTT; Pires et al., 2007; Schoenberg et al.,
2012), and insulin responsiveness is negatively correlated with circulating FFA (Oikawa and
Oetzel, 2006). Furthermore, inducing hyperlipidemia in dairy cows by intravenous infusion of
tallow emulsion can impair glucose clearance during a GTT or ITT, reflecting lower
responsiveness to insulin during elevated hepatic FA influx (Pires et al., 2007a).
In monogastrics, molecular mechanisms of FFA-mediated insulin resistance are wellestablished. For example, administering saturated FFA to muscle cells decreases phosphorylation
(i.e., activation) of AKT (Chavez et al., 2003). Additionally, elevation in FFA can result in serine
(rather than tyrosine) phosphorylation of IRS-1, leading to disruption of downstream
phosphorylation and insulin signal transduction (Le Marchand-Brustel et al., 2003). Also, protein
kinase C-ζ activation serves as a negative regulator for AKT (Konishi et al., 1994; Doornbos et
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al., 1999). While changes in systemic insulin sensitivity during the peripartum is well established
in dairy cows, molecular mechanisms contributing to insulin resistance in cows experiencing
overnutrition are not well understood. It has been proposed that peripheral-tissue specific insulin
resistance develops postpartum in cows prone to high weight loss, as evidenced by lack of
phosphorylation of AKT in adipose tissue postpartum compared to prepartum (Zachut et al.,
2013). However, recent evidence confounds this hypothesis. For example, Mann and colleagues
(2016) measured phosphorylation of AKT and hormone sensitive lipase (HSL) in adipose tissue
of cows overfed by 50% of requirements in the dry period compared to controls, and detected no
differences between groups. This can potentially be explained by the fact that the high energy
diet did not cause a significant increase in BCS compared to controls. They did observe
phosphorylation of HSL is increased postpartum, which is supported by the work of Locher and
coworkers (2011). They suggest the reason for an increase in circulating FFA postpartum in
cows overfed prepartum is not due to changes in adipose tissue insulin signaling, but rather due
to lower circulating concentrations of glucose and insulin postpartum contributing to greater
negative energy balance, and due to an increase in total amount of mobilized adipose tissue mass
(Mann et al., 2016).
Potential role of ceramide as a mediator of insulin resistance
In overweight, type 2 diabetic monogastrics, the antagonistic effects of FFA on insulin
sensitivity are mediated in part by the sphingolipid ceramide (Holland and Summers, 2008).
Ceramides were previously described as merely structural elements of cell membranes; however,
recent research implicates ceramides as bioactive lipid mediators that play a role in a number of
cellular processes including cell cycle arrest, apoptosis, and stress responses (Hannun, 1996).
Ceramide synthesis involves three different pathways including de novo synthesis,
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sphingomyelin hydrolysis, and the salvage pathway. Distinct activation of these pathways may
be possible due to compartmentalization of enzymes that contribute to ceramide formation
(Kitatani et al., 2008). First, ceramides can be generated de novo by condensation of palmitoylcoA and serine in a reaction catalyzed by serine palmitoyl transferase (SPT) to form 3ketosphinganine (Merrill and Wang, 1986). The keto group is then reduced using 3ketodihydrosphingosine reductase to form sphinganine (Merrill and Wang, 1986; Perry 2002;
Menaldino et al., 2003). Dihydroceramide synthase then adds an acyl group, forming a
dihydroceramide (Merrill and Wang, 1986; Perry 2002; Menaldino et al., 2003). Different
dihydroceramide synthase isoforms exist to produce specific ceramides with unique carbon chain
length, which accounts for their diversity (Mizutani et al., 2005; Lahiri et al., 2005; Park and
Pewzner-Jung, 2013). Dihydroceramide desaturase then converts dihydroceramide to ceramide,
which contains a 4, 5-trans-double bond in the sphingosine group (Merrill and Wang, 1986;
Rother et al., 1992, Perry 2002; Menaldino et al., 2003). Following synthesis, ceramide can be
glycoslyated to form glucosylceramide, lactosylceramide, and gangliosides (Reynolds et al.,
2004). Second, ceramides can also originate from sphingomyelin hydrolysis mediated by
sphingomyelinases (SMases) classified as acid-, alkaline-, or neutral-SMase based on their
optimal pH (Callahan et al., 1983; Nilsson, 1969; Wu et al. 2010). Third, the salvage pathway
involves use of several enzymes including SMases, glucocerebrosidase, ceramidases, and
(dihydro) ceramide synthases to breakdown complex sphingolipids into sphingosine and
regenerate ceramide (Riboni et al., 1997; Kitatani et al., 2008). Researchers estimate that 50-90%
of sphingolipid biosynthesis comes from recycling of long chain-sphingoid bases (Gillard et al.,
1998; Tettamanti et al., 2003), which suggests perhaps sphingolipid breakdown plays an
important role in ceramide biosynthesis and signal transduction (Kitatani et al., 2008).
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In obese humans with type 2 diabetes, the severity of insulin resistance is correlated with
circulating 18:0-, 20:0-, 24:1-, 24:0- and total ceramide (Cer; Haus et al., 2009). Moreover, the
ability of the liver to de novo synthesize ceramide due to an oversupply of FFA has been
previously established in humans and rats (Holland et al., 2007; Watt et al., 2012). Specifically,
an elevation in SFA (e.g., palmitate) contributes to ceramide production through condensation
with SPT in the first step of de novo ceramide synthesis. Ceramide blocks normal insulin
signaling by recruiting protein kinase C-ζ and inactivating AKT (Powell et al., 2003; Hajduch et
al., 2008). Phosphodiesterase 3B is inactivated as a result, leading to accumulation of cAMP and
enhanced lipolysis (Mei et al., 2002; Holm 2003). Thus, ceramide appears to work in a vicious
cycle whereby NEB leads to mobilization of FFA, elevated FFA concentration leads to ceramide
formation, and ceramide accrual further activates lipolysis potentially leading to non-alcoholic
fatty liver disease and other metabolic disorders in humans. However, these mechanisms
remained to be confirmed in ruminants.
Ceramide’s ability to antagonize insulin action may be a function of its acyl moiety
(Boon et al., 2013, Raichur et al., 2014; Turpin et al., 2014). Controversy exists about the role of
16:0- vs. 24:0-Cer on insulin resistance (Raichur et al., 2014; Turpin et al., 2014). The most
abundant ceramide in human circulation is 24:0-Cer, which has been identified in association
with type 2 diabetes (Haus et al., 2009). Increases in LDL containing either 16:0- or 24:0-Cer
decreases systemic and skeletal muscle glucose uptake in lean mice by inhibiting insulinstimulated AKT phosphorylation (Boon et al., 2013). In contrast, when a high fat diet was
administered to ceramide synthase-2 knockout mice displaying lower hepatic 24:0-Cer, 16:0-Cer
was increased through overexpression of ceramide synthase 6, and insulin sensitivity was
hindered. Similarly, Turpin and coworkers (2014) found that in adipose tissue of obese humans,
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ceramide synthase 6 gene expression is increased causing an elevation in 16:0-Cer and insulin
resistance. However, Meikle and colleagues (2013) found that 16:0-Cer and type 2 diabetes are
not related. Therefore, the effect of 16:0- and 24:0-Cer on insulin sensitivity may be due to either
intracellular or extracellular compartmentalization of ceramide; however, future research is
required.
We have recently demonstrated that greater adiposity is associated with a more extreme
loss in body condition during the peripartum and that overweight cows (increased BCS) have
elevated plasma glucose, insulin, FFA, and lower estimated insulin sensitivity compared to their
lean counterparts (Rico et al., 2015). Additionally, circulating ceramides are elevated in dairy
cows during the transition period, are positively correlated with FFA, and are negatively
correlated with insulin sensitivity (Rico et al., 2015; Rico et al., 2016; Mathews et al., 2016).
Moreover, supplementing cows with palmitatic acid during mid-lactation increases hepatic
synthesis and plasma accumulation of ceramide, decreases insulin sensitivity, and improves milk
production (Rico et al., 2016); thus demonstrating that ceramide may be able to restore insulin
resistance during positive energy balance via ceramide-dependent mechanisms.
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Chapter 3
NUTRIENT RESTRICTION INCREASES CIRCULATING AND HEPATIC
CERAMIDE IN DAIRY COWS DISPLAYING IMPAIRED INSULIN TOLERANCE
Introduction
Development of insulin resistance in dairy cattle represents a homeorhetic adaptation to
support milk production (Bell, 1995). Specifically, reduced insulin sensitivity in adipose and
skeletal muscle tissue develops during early lactation as a means to partition glucose to the
mammary gland (Bell, 1995). Increased energy requirements for lactation coupled with
suppressed energy intake promotes accelerated adipose tissue lipolysis and hepatic lipid
deposition during the peripartum which represent unfavorable conditions that promote metabolic
disease when uncontrolled (e.g., fatty liver and ketosis). As lactation advances beyond peak milk
production, insulin sensitivity and metabolic health improves as positive energy balance is
restored (Bell, 1995; McNamara and Hillers, 1986). Characterization of the mechanisms that
regulate insulin action in dairy cows is necessary to identify approaches to improve cow health
and lifelong milk production.
The sphingolipid ceramide mediates the pathophysiology of insulin resistance in diabetic
monogastrics (Holland et al., 2007; Chavez and Summers, 2012). Membrane ceramide inhibits
insulin signaling by recruiting protein kinase C-ζ and inactivating AKT (Powell et al., 2003;
Hajduch et al., 2008). As a consequence, PDE3B is inactivated, cAMP accumulates, and the
lipolytic release of FFA is enhanced (Mei et al., 2002; Holm, 2003). We have recently
established that circulating ceramide (e.g., 24:0-Cer) is elevated in dairy cows transitioning from
gestation to lactation (Rico et al., 2015), and lactating cows fed supplemental palmitic acid (Rico
et al., 2016). Moreover, we demonstrated that circulating ceramide is positively related to FFA
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supply and inversely associated with insulin sensitivity (Rico et al., 2015; Rico et al., 2016;
Mathews et al., 2016). The central hypothesis of this manuscript is that ceramide may represent a
maternal adaptation to support nutrient partitioning and milk production in dairy cattle.
Considering that the relationship between dietary energy intake and ceramide supply has
not been investigated in dairy cattle, our objective was to evaluate changes in circulating and
hepatic ceramide levels during controlled feed restriction. To assess ceramide responses, a feed
restriction protocol was employed to promote lipolysis and insulin resistance, and ceramide
levels were quantified using mass spectrometry. The effects of nicotinic acid (NA), a known
suppressor of lipolysis (Pires et al., 2007; Pires and Grummer 2007b), was also assessed,
although we recognized that chronic NA treatment can antagonize insulin action (Heemskerk et
al., 2014; Pires et al., 2016). Herein, it was confirmed that feed restriction increases circulating
and hepatic ceramide; however, NA treatment was unable to prevent ceramide accrual or
improve insulin sensitivity. In support of our previous work, these data revealed that circulating
and hepatic 24:0-Cer are inversely associated with insulin sensitivity.
Materials and Methods
Experimental Design
Experimental procedures were approved by the West Virginia University Institutional
Animal Care and Use Committee (Morgantown) and were completed at the West Virginia
University Animal Science Farm. Nine non-lactating, non-pregnant Holstein cows (2.6 ± 0.9
parity; 617 ± 51 kg body weight (BW); 3.0 ± 0.3 body condition score (Wildman et al., 1982)
were housed in a free stall barn and trained to access feed by using Calan gate feeders (American
Calan Inc., Norwood, NH). Cows were enrolled 14 d before treatment and randomly allocated to
1 of 3 groups in a replicated 3×3 Latin square design. Cows were ad libitum fed, nutrientrestricted (NR), or NR with nicotinic acid (NA; 5 mg of NA/h per kg BW; delivered i.v.) for 34
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h. When provided access, cows were ad libitum fed (0800 and 1800 h) a mixed ration of grass
hay and ground corn to meet or exceed requirements (Table 3.1) (NRC, 2001). Nutrientrestricted cows were provided with vitamins and minerals that were mixed with wheat middlings
as a carrier (1 kg/d) to meet requirements (NRC, 2001). Nicotinic acid (99% purity; Vetagro
S.p.A., Reggio Emilia, Italy) was administered to suppress lipolysis, and prepared with
equimolar amounts of sodium bicarbonate to facilitate solubilization in saline in accordance with
previously established methods (Pires et al., 2007b). Post-treatment, all cows were provided ad
libitum access to feed and monitored for an additional 8 h. Two 14-d recovery periods were
included. Because fluctuations in circulating progesterone may influence insulin sensitivity
(Livingstone and Mary, 2002), an intravaginal progesterone-releasing device (1.38 g; Eazi-Breed
CIDR; Zoetis Inc., Florham Park, NJ) was inserted and replaced every 7 d throughout
experimentation. Free access to water was ensured at all times. Body weights and body condition
scores were recorded within 36 h of the initiation of treatment.
Sampling Procedures
Following established procedures (Mathews et al., 2016; Pires and Grummer, 2007a),
cows were fitted with two indwelling jugular catheters (Micro-Renathane implantation tubing;
Braintree Scientific, Inc., Braintree, MA) into each jugular vein 36 h prior to the initiation of
treatments. Patency was maintained by flushing with heparinized saline every 12 h when not in
use. Blood (8 mL) was collected at -48 (0700 h), -24, 0, and every 2 h until h 34, relative to the
start of treatment. Post-treatment, blood was collected at 1, 2, 4, 6, and 8 h (35, 36, 38, 40, and
42 h relative to the start of treatment, respectively). Blood samples were transferred into a glass
test tube and serum was harvested following centrifugation (3,400 × g for 10 min at 4°C), frozen
on dry ice, and stored at -80°C until analyzed.
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Liver biopsies were performed at h 32 relative to the start of treatment using aseptic
techniques as previously described with modifications (Rico et al., 2016; Hughes, 1962). Hair
was clipped surrounding the 11th intercostal space, and the incision site was sanitized with iodine
scrub and anesthetized with lidocaine HCl (5 to 10 mL; Vedco, Inc., Saint Joseph, MO)
delivered subcutaneously. Following tissue collection, the biopsy site was stapled and sprayed
with antiseptic. Tissue was snap-frozen in liquid nitrogen and stored at −80°C. At h 33 of
treatment, an ITT (0.1 IU/kg of BW) was performed. Additional blood samples (8 mL) were
collected at -10, 0, 10, 20, 40, 50, and 60 min relative to insulin infusion. Blood samples were
processed as described above.
Sample Analyses
Daily dry matter contents of the mixed ration were determined by drying at 60°C until a
static weight was observed. Mixed rations were composited and analyzed by near infrared
reflectance spectroscopy (Cumberland Valley, Cumberland, MD; AOAC International, 1995;
method 989.03). Serum concentrations of FFA, triacylglycerol, glucose, and total cholesterol
were determined by enzymatic methods using commercial kits (HR Series NEFA-HR (2), LType TG M, Autokit Glucose, and Cholesterol E, respectively; Wako Chemicals USA, Inc.,
Richmond, VA). All spectrophotometric measurements were conducted using a SpectraMax Plus
384 Microplate Reader (Molecular Devices, Sunnyvale, CA). Intra- and inter-assay CV were 3.2
and 6.8%, 2.8 and 4.1%, 3.6 and 4.6%, and 3.8 and 14.2% for FFA, triacylglycerol, glucose, and
total cholesterol, respectively.
Ceramides were extracted from serum and liver using a modified Bligh and Dyer
procedure including 12:0-Cer as an internal standard (Avanti Polar Lipids, Alabaster, AL;
(Haughey et al., 2004; Bandaru et al., 2013). Sample extracts were injected using a LC-20A
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HPLC (Shimadzu Corp., Kyoto, Japan) and separated by gradient elution using a C18 reversephase column (ACE Technologies LTD., Aberdeen, Scotland). Samples were analyzed using an
electrospray ionization source operating in positive ion mode that was coupled to a triple
quadrupole mass spectrometer (5500 QTRAP, Sciex Inc. Thornhill, ON, Canada). Ion spray
voltage was 5,500 at a temperature of 500°C and a collision gas setting of 9 psi. The declustering
potential, entrance potential, and collision cell exit potential were set at 80, 12, and 10 V,
respectively. Individual ceramide species were detected by multiple reaction monitoring of the
[M+H]+ molecular ion with transition ion of 264.2 m/z. A ten-point calibration curve (0.5 to 500
ng/mL) was constructed by plotting the area under the curve for 16:0-, 18:0-, 20:0-, 22:0-, and
24:0-Cer (Avanti Polar Lipids). Normalized ceramide concentrations were estimated by curve
fitting the identified ceramide species based on acyl-chain length. Spectral data quantitation was
performed using Analyst 1.6.3 (Sciex Inc).
Calculations and Statistical Analyses
The area under the curve (AUC) for serum FFA (duration of treatment; AUC0-32 h) or
glucose AUC (duration of ITT; AUC0-60 min) was calculated using the trapezoidal method as
previously described by (Pires and Grummer, 2007b). Glucose clearance rate (%/min during
ITT; CR40 min) = [(ln) glucose level at baseline (average of -10 and 0 min) – (ln) glucose level at
time point 40 min)/40] × 100 (Pires and Grummer, 2007b. Data were analyzed using a mixed
model with repeated measures including the random effect of cow and fixed effects of treatment,
time, and their interaction in SAS (version 9.3, SAS Institute Inc., Cary, NC). When necessary,
data were log transformed. Outliers were identified (studentized residuals > 3 or < -3) and
removed from analysis (typically no more than 1 per variable). Parametric Pearson correlations
were performed to determine associations between ceramide levels and insulin-stimulated
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glucose disposal during an ITT. All results are expressed as least square means unless otherwise
noted. Significance was determined at P ≤ 0.05 and trends toward significance were considered
at 0.05 < P ≤ 0.10.
Results
Prolonged intravenous NA partially suppresses lipolysis
Daily dry matter intake for all cows was comparable prior to treatment (19 ± 0.55 kg/d; P
= 0.49) and ad libitum fed cows consumed 20 ± 1.08 kg/d during treatment. Relative to feeding,
NR increased lipolysis by h 2 (103 vs. 58 µM; P <0.05), a response that progressively increased
for the duration of treatment (725 vs. 69 µM at h 32; P <0.001; Figure 3.1A). In response to NA
infusion in NR cows, adipose tissue lipolysis was suppressed (P < 0.001; Figure 3.1A); however,
long-term NA infusion was unable to prevent the gradual rise in FFA caused by feed removal.
Collectively, adipose tissue lipolysis was suppressed 55% in cows infused NA (FFA AUC0-32 h;
Fed, 125,131; NR, 793,641; NR + NA, 423,558 [μmol/L × 32 h]; SEM = 43,822; P <0.001).
Coinciding with lower hepatic FFA delivery, serum concentrations of triacylglycerol were
suppressed in NR + NA treated cows, relative to the ad libitum fed or NR treatment (h 8 or 32; P
< 0.05; Figure 3.2A). During treatment, overall glucose homeostasis was maintained; however,
we observed a short-term decline in circulating glucose from h 8 through 14 of NR + NA
treatment (Figure. 3.2B). Additionally, NR in the absence or presence of NA infusion increased
serum total cholesterol (Figure 3.2C), an effect previously observed (Sävendahl and Underwood,
1999).Following treatment removal, serum FFA surged to 2,911 μM (P <0.01; Figure 3.1B), and
this response was accompanied by an increase in serum triacylglycerol and glucose
concentrations (Figure 3.2A-B).

23

Nutrient restriction increases serum and hepatic ceramide
The ability of ceramide to inhibit insulin sensitivity may be influenced by the moiety
(Boon et al., 2013; Raichur et al., 2014; Turpin et al., 2014). In our current study, we observed a
greater contribution of 16:0-Cer to the total ceramide pool in non-pregnant and non-lactating
dairy cows (Figure 3.3A and 3.4A). Consistent with previous observations in peripartal dairy
cows experiencing negative energy balance (Rico et al., 2015), we observed a marked increase in
circulating ceramide during nutrient restriction, relative to ad libitum feeding (Figure 3.3B-F).
For example, NR cows exhibited increased circulating 16:0- and 24:0-Cer (75 and 78% by h 32,
respectively; P <0.001). Moreover, re-feeding for 8 h decreased circulating 16:0- and 24:0-Cer
by approximately 23% (P <0.001). Similar effects were observed for serum 18:0-, 20:0-, and
22:0-Cer in NR treated cows. Although NA infusion partially suppressed lipolysis,
administration of NA was unable to prevent the rise in circulating ceramide caused by nutrient
restriction. Most notably, serum 22:0- and 24:0-Cer levels were enhanced by NA infusion.
Coinciding with the surge in circulating FA, terminating NA infusion promoted a short-term
burst in serum 18:0-Cer levels (2 h post). Although less dramatic, a similar increase post NA
infusion was observed for serum 16:0- and 20:0-Cer concentrations.
The ability of liver to synthesize and export ceramide has been previously established
(Haus et al., 2009; Watt et al., 2012). Relative to ad libitum feeding, NR with or without NA
infusion increased hepatic ceramide (56 to 116%; Figure 3.4B). Moreover, we observed a
positive association between serum and hepatic ceramide concentrations (Figure 3.4C).
Ceramides are Inversely Related to Insulin Tolerance
In order to validate previous data that demonstrates impaired insulin sensitivity during
negative energy balance (Pires and Grummer, 2006b; Oikawa and Oetzel, 2006), we assessed
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changes in circulating glucose in response to an insulin challenge. We observed an inhibition of
insulin-stimulated glucose disposal following NR treatment (Figure 3.5). Specifically, NR and
NR + NA decreased CR40 min (Fed, 1.76; NR, 1.36; NR + NA, 0.88 [%/min]; SEM = 0.16; P <
0.001) and increased glucose AUC0-60 min (Fed, 2259; NR, 2651; NR + NA, 2793 [mg/dL × 60
min]; SEM = 169; P < 0.05) relative to ad libitum fed cows. Additionally, serum glucose
concentrations rebounded 55% from min 40 to 60 in cows fed ad libitum, a response not
observed for the NR or NR + NA treatment. Administration of NA was unable to restore
systemic insulin action during nutrient restriction. To determine whether systemic insulin
tolerance is related to circulating or hepatic ceramide supply, we performed a Pearson correlation
analysis. We detected an inverse relationship between very long chain ceramide (i.e., serum and
hepatic 22:0- and 24:0-Cer) levels and CR40 min (r = -0.51 to -0.42, P < 0.05; Figure 3.6A), a
response not observed for 16:0-, 18:0-, 20:0-Cer, or FFA. We also observed a positive
relationship between 22:0- and 24:0-Cer, and glucose AUC0-60 min (Figure 3.6B). Although 16:0-,
18:0-, and 20:0-Cer were not related to systemic insulin action, our results support an inverse
relationship between very long chain ceramides (22:0- and 24:0-Cer) and systemic insulin
tolerance.
Discussion
Development of insulin resistance in dairy cows is mediated in part by the actions of
growth hormone and glucocorticoids, and represents a key maternal adaptation to partition
energy towards the mammary gland as a means to support milk production for the neonate (Bell,
1995). Onset of insulin resistance will promote glucose sparing, increase lipolysis in adipose
tissue, and enhance availability of FFA for oxidation or milk fat synthesis. Unfortunately, the
modern early lactation dairy cow depends on insulin antagonism during a stage of lactation
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characterized by decreased intake and increased energy requirements to sustain copious milk
production. Hepatic triacylglycerol accumulation may ensue in response to sustained elevations
in circulating FFA. These conditions can promote fatty liver disease and ketosis which can
compromise the health, fertility, and longevity of the cow. In monogastrics, ceramide is a central
mediator of insulin resistance, lipolysis, and hepatic lipid accumulation (Chavez and Summers,
2012; Mei et al., 2002; Xia et al., 2015), and we have observed increased plasma ceramide levels
in dairy cows transitioning from gestation to lactation (Rico et al., 2015). In our current study,
we validated previous work that demonstrated impaired insulin action in response to energy
deficit (Pires et al., 2007; Oikawa and Oetzel, 2006). More importantly, we established that
circulating and hepatic ceramide accrual develops in nutrient-restricted dairy cows experiencing
impaired insulin tolerance.
Elevations in circulating FFA concentrations can cause insulin resistance in skeletal
muscle and adipose tissue of monogastrics (Summers, 2006; Funaki, 2009). Likewise, induction
of hyperlipidemia by nutrient restriction or tallow infusion can impair insulin sensitivity in dairy
cows (Pires et al., 2007; Pires and Grummer, 2007a). These researchers postulate that
establishment of FFA-induced insulin resistance in adipose tissue of peripartal dairy cows may
support a vicious cycle in which higher FFA concentrations attenuate insulin signaling and
sustain adipose tissue mobilization. Comparable to Pires and colleagues (Pires et al., 2007) our
nutrient restriction protocol increased circulating FFA levels and impaired glucose clearance
following an insulin challenge; however, intravenous NA infusion was unable to restore insulin
sensitivity albeit lipolysis was partially suppressed and circulating triacylglycerol was
intermittently lower. Despite reduced FFA supply, others have demonstrated impaired insulin
sensitivity following 48 h NA administration (3 mg/h per kg of BW; delivered abomassally) in
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cows restricted to 33% of ad libitum intake (Pires et al., 2016). Moreover, long-term niacin
feeding in mice (15 wk dietary supplementation at 0.3% wt/wt) inhibits systemic insulin
sensitivity and blocks insulin-inhibited lipolysis by downregulating PDE3B (Heemskerk et al.,
2014). In our investigation, the inability of 32 h NA infusion to completely suppress FFA
mobilization may have involved a similar mechanism. In contrast to our findings and others
(Heemskerk et al., 2014; Pires et al., 2016), earlier work (Pires et al., 2007) has revealed that NA
administration (6 mg/h per kg of BW delivered abomassally) for a shorter duration (11 h) can
enhance insulin-stimulated glucose clearance in feed-restricted dairy cows. Interestingly, we did
not observe an increase in 22:0- or 24:0-Cer until h 16; therefore, the insulin-sensitizing effects
of short-term (<16 h) NA administration at supraphysiological doses may not be accompanied by
elevated ceramide. It is clear that the ability of NA to inhibit insulin sensitivity and lipolytic rate
are dependent on the duration and dose of the treatment regimen; however, the mechanism of
action remains uncertain. Therefore, we explored whether ceramide was related to energy deficit
in the absence or presence of 34 h NA infusion.
Fatty acid oversupply contributes to increased hepatic de novo ceramide synthesis and
secretion in humans and rats (Holland et al., 2007; Watt et al., 2012). In turn, lipoprotein
ceramide mediates the development of insulin resistance in part by interfering with protein
kinase B signaling (Boon et al., 2013; Stratford et al., 2004). Our observed elevations in NRinduced FFA levels developed concurrently with the accumulation of ceramide in liver and
serum, a positively correlated relationship suggesting coordinated hepatic synthesis and export.
Moreover, following the termination of NA infusion, we observed a FFA surge-dependent
increase in 16:0-, 18:0-, and 20:0-Cer thus indicating that rapid ceramide synthesis is possible in
cows. This response developed in parallel with a rapid increase in circulating triacylglycerol and

27

glucose, likely caused by increased hepatic triacylglycerol export and glycerol-dependent
gluconeogenesis (Aschenbach et al., 2010), respectively. Coinciding with improved energy
balance, circulating ceramide was lowered by re-feeding. We have previously demonstrated a
positive relationship between elevated circulating ceramide and FFA levels in peripartal dairy
cows experiencing negative energy balance (Rico et al., 2015). The current study confirms an
inverse relationship between circulating ceramide and glucose-stimulated FFA disappearance,
thus supporting a role for ceramide as a lipolytic mediator (Rico et al., 2016). Additionally, cellpermeable ceramide decreases PDE3B activity and inhibits insulin-induced anti-lipolysis in 3T3L1 adipocytes (Mei et al., 2002). Collectively, our data supports a lipolytic role for ceramide
when cows experience increased energy demand.
Considering that FFA serve as substrate for hepatic de novo ceramide synthesis (Merrill,
2002), we anticipated lower hepatic and circulating ceramide concentrations in response to NA
infusion. Contrary to our hypothesis, inhibition of lipolysis by NA was unable to suppress
ceramide accumulation in response to feed removal. Unexpectedly, NA infusion selectively
enhanced very long chain 22:0- and 24:0-Cer concentrations. The inability of NA to prevent NRinduced ceramide accrual may explain why insulin-stimulated glucose disposal remained
unchanged, relative to NR cows. Accumulation of ceramide during suppressed lipolysis suggests
that alternative mechanisms independent of substrate supply for serine SPT and ceramide
synthase within the de novo synthesis pathway are responsible. For instance, NA may have
directly activated SPT. In support, Tanno and coworkers (2000) demonstrated that nicotinamide
increases ceramide levels in human keratinocytes by enhancing SPT transcription and activity,
and pyridoxal-5’-phosphate (vitamin B6) is a known cofactor for SPT (Wadsworth et al., 2013).
Alternatively, NA infusion may have upregulated other ceramide generating pathways including
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sphingomyelin hydrolysis or salvage synthesis (Hirabayashi et al., 2006). Considering that NA
may upregulate ceramide synthesis during a catabolic state and a comparison of 14 studies
indicated that niacin lowered FFA once (NRC, 2001), we contemplate whether supplementing
NA at practical feeding levels during early lactation may inadvertently exacerbate insulin
resistance.
The ability of ceramide to inhibit insulin sensitivity may be dependent upon the acyl
moiety of the sphingolipid (Boon et al., 2013; Raichur et al., 2014; Turpin et al., 2014). In our
investigation, NR increased serum 16:0-, 18:0-, 20:0-, 22:0- and 24:0-Cer; however, the
observed inverse relationship between ceramide and insulin sensitivity (i.e., CR40 min or AUC0-60
min)

was reserved for the 22:0 and 24:0 moiety. We have made similar observations in peripartal

and mid-lactation dairy cows displaying enhanced total ceramide supply (Rico et al., 2015; Rico
et al., 2016). Whereas we have previously established that 24:0-Cer is the most abundant
ceramide in lactating dairy cows, our current study demonstrated that 16:0-Cer was the
predominant ceramide in non-pregnant, non-lactating dairy cows. Considering that the
contribution of very long chain ceramides to the total ceramide pool increases as cows transition
from gestation to lactation and decline beyond peak milk yield (Rico et al., 2015; Rico et al.,
2016), relative to 16:0-Cer, our observed difference in hepatic and serum sphingolipid profiles
likely reflect the physiological state of the animal. In support of the role of 24:0-Cer as an insulin
antagonist, Boon and coworkers (2013) demonstrated that rodents infused with low density
lipoproteins enriched with 24:0-Cer display impaired insulin-stimulated glucose uptake and
protein kinase B activation. Additionally, Meikle et al. (2013) found that circulating 16:0-Cer
elevation and the development of type 2 diabetes were not related. In contrast, others have
proposed that skeletal muscle 16:0-Cer is a proapoptotic mediator of insulin resistance in
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response to high-fat feeding, and 24:0-Cer confers antiapoptotic and proliferative functions
(Raichur et al., 2014; Turpin et al., 2014). With these uncertainties recognized, the ability of
specific ceramides to inhibit insulin action may be influenced by their compartmental origin.
Our work represents the first investigation to explore the relationship between controlled
nutrient restriction, ceramide supply, and systemic insulin sensitivity in dairy cows. We
demonstrated that hepatic and serum ceramide levels increase in response to rising circulating
FFA levels and insulin resistance caused by nutrient restriction. Moreover, we established that
improving the energy status of the cow can lower ceramide concentrations. In support of our
previous findings in peripartal and mid-lactation dairy cows, we confirm that the inverse
relationship between ceramide levels and insulin sensitivity is specific for ceramides with a 22:0
or 24:0 moiety. We also demonstrated that long-term NA administration does not prevent the rise
in ceramide or insulin antagonism caused by nutrient restriction. Our data suggest that ceramides
are fundamentally involved in the adaptive metabolic changes associated with the onset of a
catabolic state in dairy cows.
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TABLES AND FIGURES

Table 3.1. Ingredients and nutrient composition (% of dry
matter unless otherwise noted) of experimental diet when
offered.
Ingredient1
Grass hay

37.9

Corn grain mix2

33.1

Dairy pellets3

29.0

Nutrient composition

1

Dry matter, %

85.2

Crude protein

19.3

Neutral detergent fiber

37.8

Acid detergent fiber

24.6

Starch

15.6

Crude fat

2.8

Ash

7.8

Net energy for lactation, Mcal/kg of dry matter

1.5

Ingredients were composited weekly.

2

Corn grain mix contained (as fed) 39.9% ground corn
grain, 46.5% soybean meal, 1.7% magnesium sulfate, 0.9%
trace mineral salt, 0.3% Sel-Plex 600 (Alltech,
Nicholasville, KY), 0.6% Zinpro Availa-Plus (Zinpro
Corp., Eden Prairie, MN), 8.5% Zar-Min (ZEO Inc.,
McKinney, TX), 0.4% vitamin premix ADE, and 1.2%
vitamin premix E.
3

Dairy pellets contained (as fed) 33.1% soy hulls, 38.2%
corn, 25.2% soy meal, 1.1% urea, 0.9% limestone, 0.4%
calcium phosphate, 0.2% magnesium oxide, 0.5% trace
mineral salt, and 0.4% vitamin premix ADE.
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Figure 3.1. Intravenous infusion of nicotinic acid (NA) partially suppresses lipolysis in nutrientrestricted (NR) dairy cows. Serum fatty acid concentrations (A) during and (B) following
treatment in cows ad libitum fed, NR, or NR plus NA infusion (NR + NA). Intravenous infusion
of NA was delivered at 5 mg of NA/h per kg BW. Data are represented as least squares means
and their standard errors

Figure 3.2. Circulating triacylglycerol, glucose, and total cholesterol concentrations in dairy
cows ad libitum fed, nutrient-restricted (NR), or NR plus nicotinic acid infusion (NR + NA).
Serum (A) triacylglycerol, (B) glucose, and (C) total cholesterol concentrations during or
following treatment. Vertical dashed line reflects termination of saline or NA (delivered at 5 mg
of NA/h per kg BW) infusion. Data are represented as least squares means and their standard
errors
Figure 3.3. Nutrient restriction increases circulating ceramide in dairy cows. Serum ceramide
(Cer) (A) composition and (B-F) concentrations in dairy cows ad libitum fed, nutrient-restricted
(NR), or NR plus nicotinic acid infusion (NR + NA). Composition of serum ceramides was
evaluated at h 32. Vertical dashed line reflects termination of saline or NA (delivered at 5 mg of
NA/h per kg BW) infusion. Data are represented as least squares means and their standard errors.
Differing superscripts reflect statistical differences between treatments within a time point, P <
0.05

Figure 3.4. Nutrient restriction increases hepatic ceramide in dairy cows. Liver ceramide (Cer)
(A) composition and (B) concentrations in dairy cows ad libitum fed, nutrient-restricted (NR), or
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NR plus nicotinic acid infusion (NR + NA). (C) Random regression analysis between serum and
hepatic total ceramide concentrations at h 32. Intravenous infusion of NA was delivered at 5 mg
of NA/h per kg BW. Concentrations for individual ceramide moieties are represented as least
squares means and their standard errors. Coefficient of determination (R2) represents the
association between observed and model predicted values when accounting for the random effect
of cow. Differing superscripts reflect statistical differences between treatments within a time
point, P < 0.05

Figure 3.5. Nutrient restriction decreases insulin sensitivity in dairy cows. Serum glucose
response to an insulin tolerance test in dairy cows ad libitum fed, nutrient-restricted (NR), or NR
plus nicotinic acid infusion (NR + NA). Insulin was administered at 0.1 IU/kg of BW.
Intravenous infusion of NA was delivered at 5 mg of NA/h per kg BW. The tolerance test was
performed at h 33 of treatment. Baseline values are represented as the average of -10 and 0 min,
relative to start of insulin challenge. Data are represented as least squares means and their
standard errors

Figure. 3.6 Very long chain ceramides are inversely related to insulin tolerance in dairy cows.
Relationship between ceramide (Cer) supply and insulin tolerance in dairy cows ad libitum fed,
nutrient-restricted (NR), or NR plus nicotinic acid infusion (NR + NA). Intravenous infusion of
NA was delivered at 5 mg of NA/h per kg BW. Measurements of insulin tolerance include
glucose clearance rate (CR40 min; 40 min following insulin administration) and glucose area under
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the curve (AUC0-60 min; duration of test). Data reflect serum and liver samples collected at h 32 of
treatment. **P < 0.01, *P < 0.05, †P < 0.10
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Chapter 4
EFFECTS OF PREPARTUM ADIPOSITY ON PERIPARTAL SYSTEMIC AND
LOCALIZED INSULIN SENSITIVITY IN DAIRY COWS
Introduction
During the gestation to lactation transition, the peripartal dairy cow exhibits a high
glucose requirement to support the growing fetus and the increased demand for milk production.
First, dramatic requirements for glucose by the placenta are increased 4-fold during late
gestation, and glucose requirements can increase 7-fold at the onset of lactation to support
mammary lactose synthesis (Bell and Bauman, 1997). Due to this dramatic increase in glucose
requirement coupled with suppressed energy intake and amplified energy expenditure, peripartal
dairy cows develop insulin resistance in adipose and muscle tissues as a metabolic adaptation to
support lactation (Bell and Bauman, 1997). Because insulin is an anti-lipolytic hormone, insulin
resistance promotes accelerated adipose tissue lipolysis and increases circulating FFA. As a
detrimental consequence, hepatic influx of FFA can be re-esterified to form triacylglycerol
(TAG). Excessive deposition of TAG in liver can increase ketogensis and compromise
gluconeogenesis (Rukkwamsuk et al., 1999; Rukkwamsuk et al., 2000). If not resolved, these
hepatic impairments can promote the development of postpartum metabolic diseases including
fatty liver disease, ketosis, retained placenta, and mastitis (Holtenius et al., 2003; Bobe et al.,
2004; Ospina et al., 2010). Onset of a metabolic disease can comprise cow longevity and
decrease producer profits. Understanding the mechanisms of metabolic disease will support
development of novel approaches to improve cow health and performance during the transition
from gestation to lactation.
Pregnant dairy cows with enhanced adiposity during late gestation are subjected to a
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greater loss in body weight and adiposity during the transition period. Moreover, overweight
dairy cows experience greater lipolytic rates and increased circulating FFA concentrations
relative to lean cows (Janovick et al., 2011; Rukkwamsuk et al., 2000). Increased hepatic lipid
deposition, ketogenesis, systemic inflammation, and oxidative stress all contribute to increased
disease risk in overweight dairy cows (Bobe et al., 2004; Bernabucci et al., 2005; Duffield et al.,
2009; Lacetera et al., 2005). Current recommendations are to minimize body fat gain during late
gestation (Overton and Waldron, 2004); however, modern dairy farms manage cows within
heterogenous groups (i.e. cows can have varying adiposity). One potential mechanism that may
explain why overweight dairy cows experience increased body fat loss during the peripartum
may involve reduced sensitivity to the pancreatic hormone insulin.
In overweight monogastrics, development of insulin resistance involves a reduction in
insulin-stimulated glucose uptake in adipocytes via mechanisms involving protein kinase B
(AKT) inactivation (i.e. dephosphorylation; Summers et al., 1998). In turn, AKT inactivation
suppresses translocation of glucose transporter-4 (GLUT4) to the plasma membrane in skeletal
muscle, cardiac, and adipose tissues (Zhao and Keating, 2007). Because insulin is an antilipolytic hormone, insulin resistance can promote adipose tissue lipolysis by activating hormonesensitive lipase (Sumner and McNamara, 2007). In the ruminant dairy cow, early evidence has
demonstrated the inactivation of AKT postpartum (Zachut et al., 2013); however, the ability of
adiposity to influence adipose tissue AKT phosphorylation status in response to insulin is
uncertain.
Development of adipose tissue insulin resistance offers a potential explanation for why
overweight cows exhibit a higher concentration of circulating FFA and a greater tendency to
develop metabolic disease. By employing several measurements of insulin sensitivity, our
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objective was to examine changes in systemic and localized insulin sensitivity in lean and
overweight peripartal dairy cows. Specifically, we utilized the hyperinsulinemic-euglycemic
(HEC; Kim, 2009) clamp method to measure glucose infusion rate in cows experiencing
sustained elevations in blood insulin concentrations. We also measured phosphorylation status of
AKT in subcutaneous adipose tissue (SubqAT), as well as circulating levels of several related
markers including insulin, FFA, and glucose. We hypothesized that enhanced adiposity in
periparturient dairy cows is associated with reduced glucose infusion during the HEC, increased
fat loss, and lower localized insulin sensitivity.
Materials and Methods
Experimental Design
Experimental procedures were approved by the West Virginia University Institutional
Animal Care and Use Committee (Morgantown). The experiment was completed at Dovan
Farms, WVU Agricultural Research and Education Partner, and a 700-Holstein cow commercial
dairy farm (located in Berlin, PA). Twenty-five pregnant, multiparous (3.6  1.60 lactations)
Holstein dairy cows were enrolled into the study 28 d before expected parturition. Five cows
were removed from the study and replaced for health reasons (2 displaced abomasum, 1 severe
mastitis, and 2 complete cessation of eating). Cows were randomly selected and immediately
allocated into one of two treatment groups per their prepartum adiposity, using a 1 to 5 body
condition score (BCS; overweight (i.e. overconditioned), 3.9  0.30 BCS or lean, 3.0  0.16
BCS; Wildman et al., 1982) and back fat thickness (BFT; overweight, 15.2  0.86 mm or lean,
10.2  0.80 mm). Cows had free access to water while fed twice daily (0700 h and 1700 h) for ad
libitum intake to meet or exceed nutrient recommendations during pregnancy and lactation.
Cows were milked twice daily (0600 and 2030 h) using a portable milking unit from parturition
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through d 12, then milked three times per day with the main herd. Body weight (BW) was
recorded weekly. Four trained examiners independently recorded BCS for individual cows. Body
condition score data for each cow was averaged weekly from d -28 to d 28 relative to parturition.
Back fat thickness was measured weekly using an ultrasound according to the methods of
Schröder and Staufenbiel (2006).
Sampling Collection
Prior to morning feeding, blood samples (10 mL) were collected via coccygeal
venipuncture weekly starting at enrollment until d -7, then daily until to d 8, followed by d 10,
12, 14, 21, and 28, relative to calving. Blood samples were placed on ice for 30 min until
centrifugation at 3,400 × g for 10 min. Plasma was then removed after centrifugation and snapfrozen in liquid nitrogen. Samples were then stored for analysis at -20ºC for no longer than two
weeks then moved to -80ºC for long-term storage. Total mixed ration (TMR) samples were
collected once every two weeks, and composited monthly for analysis. Milk samples were
collected at each milking on d 1, 3, 5, 7, 10, 12, 14, 21, and 28 relative to parturition. Samples
were kept at 4ºC and preserved using Bronopol tablets (D&F Control Systems, San Ramon, CA)
for milk composition analysis.
Liver and adipose biopsies were performed on d -12 and 10 relative to calving. For liver
biopsies, the incision site was located with the 11th intercostal space by making an incision 0.5cm through the skin. Using a custom trocar, 1 g of liver tissue was collected (Hughes, 1962) and
snap-frozen in liquid nitrogen. Within 48 h, biopsy samples were removed from liquid nitrogen
and stored at -80°C. To evaluate adipose tissue AKT activation (i.e. phosphorylation), 50-100
mg of adipose tissue was removed from the cow and incubated in DMEM medium containing
1% BSA, 1M acetate, and 5 mM glucose for 10 min at 39˚C to reflect physiological conditions.
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The tissue was then spiked with 1 mM insulin. After incubation at 39˚C for 15 min, the tissue
was removed from the solution and snap-frozen in liquid nitrogen. Additionally, an adipose
explant was harvested, placed in a cassette, and stored in formalin for histology analyses. After
tissue collection, biopsy sites were cleaned with hydrogen peroxide, stapled, and sprayed with
antiseptic (Blu-Kote; H.W. Naylor Co. INC; Morris, NY).
The HEC procedure was performed at d -10 and 12 relative to calving. Three jugular
catheters (Micro-Renathane Implantation tubing, 2.03 mm outside diameter × 1.02 mm inside
diameter; Braintree Scientific Inc., Braintree, MA; Schoenberg et al., 2012) were inserted the
evening prior to the HEC and flushed with heparinized saline every 7 h to maintain patency. One
catheter was used for blood sampling, and the other, in the opposite jugular vein, was used for
insulin and glucose infusion. Infusion lines were attached to the same catheter using an anti-y
port (Millpledge North America Inc, CA). The insulin solution was prepared using bovine
insulin stock solution (1 mg/mL; Humulin R; Lilly and Co., Indianapolis, IN), sterile saline, and
harvested plasma for insulin infusates (2.5% of total solution volume; DeFronzo et al., 1979). In
order to calculate insulin dose, body weight was recorded once daily for two days before the
HEC and averaged. Feed was removed two hours prior to the start of the HEC which occurred
prior to the morning feeding. An insulin priming dose was introduced intravenously to raise
blood insulin levels (DeFronzo et al., 1979). Subsequently, infusion lines were attached and
insulin (1 µg/kg of BW, 27 IU/mg, at 9.0 mL/h) was administered using a syringe pump (New
Era Pump Systems Inc., Farmingdale, NY). Concurrently, glucose (50% dextrose solution) was
infused using a Macro XL Plum Pump (Abbott Laboratories, North Chicago, IL) at 9 mL per h
until insulin noticeably dropped blood glucose levels measured by a hand-held glucometer
(Precision Xtra, Abbott Diabetes Care Inc., Alameda, CA). Glucose infusion rate was adjusted
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variably to reach and maintain a steady state euglycemia for 30 min minimum. The target steady
state range was considered to be the average of five basal glucose concentrations immediately
prior to HEC. The steady state range extended  10% beyond this basal average. The resulting
steady-state glucose infusion needed to maintain euglycemia was a reflection of insulin action.
Sample Analyses
Total mixed ration dry matter (DM) contents were determined by drying at 60ºC until a
static weight was achieved. Additional TMR samples were submitted to a commercial laboratory
for nutrient composition by near-infrared spectroscopy (Cumberland Valley, Cumberland, MD;
AOAC International, 1995; method 989.03). Milk samples were individually sampled and
analyzed for true protein, lactose, and fat concentrations within 1 wk of collection. Samples were
also analyzed for MUN using mid-infrared spectroscopy and SCC by flow cytometry (Dairy
One, Hagerstown, MD; AOAC, 1990; method 972.160).
Plasma glucose, FFA, and BHBA concentrations were measured using enzymatic kits
(Autokit Glucose, HR Series NEFA-HR (2), Autokit 3-HB, respectively; Wako Chemicals USA,
Inc., Richmond, VA). Serum insulin concentrations were determined using ELISA (Mercodia
Bovine Insulin ELISA; Mercodia AB, Uppsala, Sweden). All spectrophotometric measurements
were conducted using a SpectraMax Plus 384 Microplate Reader (Molecular Devices,
Sunnyvale, CA). Intra- and inter-assay CV were 4.0 and 4.2%, 3.1 and 11.9%, 2.4 and 9.1%, and
4.8 and 16.5% for glucose, FFA, BHBA, and insulin, respectively. Liver lipid was extracted and
quantified using previously described methods (Hara and Radin, 1978; Piepenbrink and Overton,
2003b).
For analysis of AKT phosphorylation, basal and insulin-stimulated SubqAT samples (~50
mg of tissue) were pulverized in a bead blender, and ice-cold lysis buffer (20 mM tris base, 50
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mM NaCl, 50 mM NaF, 5 mM Na4O7P2, 250 mM sucrose, 1% (v/v) Triton X-100, 500 mM
dithiothreitol, and protease inhibitor; 14 μl/mg of tissue) was added. Samples were centrifuged at
4˚C at 14,000 × g for 15 min. Tissue lysates were stored at -80˚C until further analysis. Loading
dye with denaturing agent was added to samples which were subsequently heated to 70˚C for 10
min and then cooled on ice. Samples were loaded on the gel at 50 μg of protein per lane. The gel
was run at 150 V for 1.5 h. The protein was transferred to a nitrocellulose membrane. The
transfer tank was submerged in ice at 120 V for 2h. The membrane was blocked for 30 min
under agitation using a 5% TBST in non-fat dry milk solution. The membranes were rinsed with
TBST and incubated overnight with primary antibodies, phosphorylated AKT (pAKT; Ser473;
1:1000) or total AKT (tAKT; 1:1000; Cell signaling, Technology, Danvers, MA) under agitation.
Membranes were washed with 1X TBST and incubated with secondary antibody (1:2000;
Alexafluor 680, Life Technologies Corporation, Eugene, OR) for 60 min with agitation at room
temperature. After incubation, the membrane was washed with TBST for 5 min, repeatedly
washed 3X. Blots were scanned using a NIR fluoresce system (Odyssey imager, LICOR
Biosciences, Lincoln, NE) and densitometry was performed using Odyssey Infrared Imaging
software (V. 3.0.29).
The adipose tissue stored in formalin were processed by a trained pathologist using a
tissue processor. The tissue was embedded using molten paraffin and allowed to harden on a
cryo console. The tissue was then removed from the mold and placed in the refrigerator until it
was sliced. Before staining, the slides were deparaffinized using xylene, and the nucleus and
cytoplasm were stained with hematoxylin and eosin, respectively. Once the slides were fixed,
adipocyte volume and counts were recorded using Image J software (NIH Image J; NIH,
Bethesda, MD).
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Calculations and Statistical Analyses
Plasma and serum data were analyzed using a mixed model with repeated measures in
SAS (V 9.3, SAS Institute Inc., Cary, NC). The model included the random effect of cow, and
the fixed effects of treatment, day relative to parturition, and their interaction. The SLICE effect
was utilized to analyze treatment differences by time. Studentized residuals < -3 or >3 were
considered outliers and were removed from the dataset (typically no more than 2 per
analysis). When necessary, data were transformed and presented in the original scale. Parametric
Pearson correlations were performed to determine associations between measures of insulin
sensitivity (GIR, SS glucose, pAKT) and adiposity, basal FFA, glucose, and BHBA. The
significance level was set at P ≤ 0.05, and trends toward significance were considered at
0.05 < P ≤ 0.10. The insulin sensitivity index was calculated as follows: SIClamp = glucose
infusion rate/ [(steady state glucose) × (steady state insulin – basal insulin)], (Muniyappa et al.,
2007).
Results
Body condition scores at enrollment were significantly different between lean (3.0  0.16)
and overweight (3.9  0.30) cows (P < 0.001). For all cows, adiposity declined during the transition
from gestation to lactation (Figure 4.1), more so for cows with enhanced prepartum adiposity.
Specifically, overweight cows experienced a 29% decrease in BCS (P <0.001; Figure 4.1A and
4.1D), a 15% decrease in BW (P <0.001; Figure 4.1B and 4.1E), and a 37% decrease in BFT
(Figure 4.1C and 4.F), relative to lean cows. Moreover, prepartum adipocyte volume was
significantly augmented for overweight cows (Figure 4.2A; P < 0.01), a response that was negated
by the transition from gestation to lactation. Although adipocyte number was not affected by
gestational adiposity, adipocyte volume decreased 14% from pre- to postpartum (Figure 4.2; P <
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0.01). Changes in adiposity loss were not due to changes in DMI, a response variable that declined
as parturition approached but was comparable for lean and overweight dairy cows (Figure 4.3).
Overweight cows tended to exhibit increased milk yields compared to lean cows (Figure
4.4A; P = 0.08), which may be attributed to more severe negative energy balance and thus
weight loss. Notably, milk yield declined briefly following the HEC procedure on d 12
postpartum (Figure 4.4A; P < 0.01), a response that can be attributed to the reduction in intake
observed the previous day (Figure 4.3). Regarding milk composition, milk fat yield and
percentage was greater in cows with enhanced prepartum adiposity (Figure 4.4B-C; P < 0.05).
Milk protein yield (Figure 4.4D; P = 0.11) and milk protein percentage were not affected by
adiposity, but milk protein percentage decreased over time as milk yield increased (Figure 4.4E;
P < 0.001). Milk lactose yield and content increased with time (P < 0.001; Figure 4.4F and
4.4G), a variable that was not influenced by adiposity.
Prepartum adiposity did not modify plasma glucose concentrations (Figure 4.5A);
however circulating glucose concentrations spiked by 20% at parturition (P < 0.001).
Overweight cows displayed elevated circulating FFA concentrations throughout the peripartum
(Figure 4.5B and Table 4.2; P < 0.001). Noticeably, overweight cows experienced a 74%
increase in FFA concentration at parturition relative to lean cows. The increase in circulating
FFA postpartum was accompanied by a reduction in circulating insulin (Table 4.2; P < 0.05). As
expected, elevated postpartum plasma FFA levels were accompanied by increased liver lipid
accumulation in overweight cows (Figure 4.6A; P < 0.05). Furthermore, hepatic lipid deposition
developed concomitantly with increased circulating BHBA levels (Figure 4.6B; P < 0.001), more
so in overweight cows.
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Measurements of systemic insulin sensitivity following the HEC are described within
Table 4.2. At the time of prepartum and postpartum HEC, BCS was significantly higher for
overweight cows compared to lean cows (P < 0.001). Prepartum, basal serum FFA and glucose
concentrations were comparable; however, postpartum basal serum FFA levels were moderately
elevated in overweight cows (P < 0.05), while plasma glucose remained stable. Additionally,
circulating basal insulin levels were not affected by adiposity (P = 0.13). During the HEC, steady
state (SS) insulin increased 332%, relative to basal insulin levels; a response that was not
modified by adiposity group. Demonstrating the effectiveness of the HEC, euglycemia was
maintained as demonstrated by SS glucose levels that were comparable to basal glucose levels.
Additionally, the HEC lowered circulating FFA levels during SS. As a direct measure of insulin
sensitivity, peripartal glucose infusion rate (GIR) was not affected by adiposity, albeit GIR
increased 63% postpartum (P < 0.01). Accounting for changes in glucose and insulin, SIClamp
values were lower for overweight cows postpartum (P < 0.05).
Under normal physiological conditions protein kinase B is phosphorylated in response to
insulin and causes GLUT4 to translocate to the plasma membrane to support glucose uptake
(Summers et al., 1998). In the present study, the ratio of basal phosphorylated AKT to total AKT
(pAKT/tAKT) in SubqAT was not affected by adiposity; however, SubqAT pAKT/tAKT
decreased from pre- to postpartum (Figure 4.7A; P < 0.05). Similarly, adiposity did not modify
pAKT/tAKT in insulin-stimulated SubqAT, but pAKT/tAKT decreased during the transition
from gestation to lactation (Figure 4.7B; P < 0.01).
Pearson correlation analysis was performed between BCS at the time of HEC (BCSHEC),
BCS loss, pAKT/tAKT in basal and insulin-stimulated SubqAT, and HEC variables (basal and
SS FFA, glucose, insulin; GIR; and SIClamp) both pre- and postpartum. Prepartum, BCSHEC
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tended to be positively correlated with basal insulin concentration (r = 0.38; P = 0.09).
Postpartum, we detected a positive correlation between BCSHEC and basal FFA (r = 0.39; P =
0.05), basal insulin (r = 0.51; P < 0.05), and SS insulin (r = 0.43; P < 0.05), and a tendency for a
positive correlation between BCSHEC and SS FFA (r = 0.39; P < 0.09). We also detected a
negative correlation between BCS loss and SIClamp postpartum (r = -0.48; P < 0.05). We detected
a negative association between prepartum basal SubqAT pAKT/tAKT and basal glucose
concentration (r = -0.50; P < 0.05), However, we were not able to detect any other correlations
between SubqAT pAKT/tAKT and HEC variables.
Discussion
Periparturient dairy cows experience a dynamic shift in adipose tissue metabolism from
energy storage at the end of lactation to rapid mobilization to meet the energy demands
associated with lactation (McNamara, 1991). During the transition from gestation to lactation,
adipocytes become insulin resistant, and basal and catecholamine-stimulated lipolysis is
enhanced, representing a homeorhetic adaptation to partition nutrients to the mammary gland and
support milk production (Bauman and Currie, 1980; McNamara, 1991; Vernon, 2005). Since
overweight cows display greater FFA mobilization, we hypothesized that overweight cows
would experience a greater reduction in systemic and adipose tissue specific insulin sensitivity
compared to lean cows during the peripartal period.
Reaffirming the adequacy of our experimental design, overweight cows had greater
prepartum BCS, BW, BFT, and adipocyte volume relative to their lean counterparts. While all
cows experienced a significant reduction in adiposity measurements during the experimental
period, overweight cows experienced a greater reduction relative to lean cows. All cows
exhibited a surge in plasma FFA and BHBA at calving, followed by sustained elevations for
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these metabolites postpartum, leading to higher hepatic lipid deposition relative to prepartum.
Further supporting the observation of greater adipose tissue mobilization, overweight cows had
higher circulating FFA levels, exhibited greater hepatic lipid deposition, and as a consequence
displayed elevated plasma BHBA levels compared to their lean counterparts. Consistent with
these observations, DeKoster and coworkers (2016) found that adipocyte size increases with
increasing BCS and that larger fat cells have higher basal and isoproterenol (an isopropyl analog
of epinephrine)-stimulated lipolytic activity. Moreover, changes in peripartal overnutrition may
mediate these responses. For example, Mann and coworkers (2016) overfed cows energy (150%
of predicted requirements) during the dry period and these cows displayed increased circulating
FFA and BHBA concentrations postpartum whereas cows that were fed a diet to meet
requirements benefited from improved metabolic health. However, Mann et al. (2016) did not
observe changes in adipose tissue hormone sensitive lipase activity in response to overfeeding,
indicating that the rate of lipolysis was similar between cows fed at different energy levels.
As expected, dry matter intake declined around parturition. This can partially be
explained by reduced rumen volume due to a growing fetus. Additionally, ketones can suppress
appetite (Allen et al., 2014), and potentially the characteristic reduction in leptin around
parturition may inactivate orexigenic hypothalamic signals (Liefers et al., 2003). While we did
not observe a difference in DMI between lean and overweight cows, the effects of adiposity on
DMI in previous studies are inconclusive (Kokkonen et al., 2005; Samii et al., 2015). Both lean
and overweight cows increased milk production over time, which can be explained by a
reduction in insulin and insulin sensitivity postpartum to facilitate glucose sparing for lactose
production. In the present study, overweight cows tended to produce more milk than lean cows.
This increase in milk yield for overweight cows is in contrast to the work of Zachut and
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coworkers (2013), who observed that cows experiencing high weight loss produced less milk
than cows experiencing low weight loss. However, it is important to note that animals diagnosed
with a clinical metabolic disease will have a reduction in milk yield (Deluyker et al., 1991; Lean
et al., 1994), and animals that are more insulin resistant will produce more milk (De Koster and
Opsomer, 2013). Therefore, a possible explanation for the increased milk yield in our overweight
cows is that they were not diagnosed with a metabolic disease. In support, other researchers have
reported elevated milk yield in cows with greater BCS when they were metabolically healthy
(Roche et al., 2006; Roche et al., 2007; McCarthy et al., 2007). Furthermore, the increased milk
yield in overweight animals suggests they were experiencing greater negative energy balance,
insulin resistance, and partitioning of nutrients to the mammary gland. In support of greater
nutrient partitioning, overweight cows displayed increased milk fat concentrations and
percentage due to elevated lipolysis and FFA availability. Lactose concentration increased over
time with increasing milk production since lactose is the major osmotic regulator of milk
volume.
Changes in circulating FFA are often related to pancreatic insulin secretion (Crespin et
al., 1969; Crespin et al., 1973). In monogastrics, insulin resistance is characterized by elevated
levels of blood insulin (Reaven et al., 1988; Thévenod, 2008), whereas ruminants experience
insulin resistance during a characteristic decline in insulin concentration postpartum (Bauman
and Currie, 1980; Bell, 1995; Bell and Bauman, 1997). We observed that independent of
adiposity, basal insulin concentrations decreased postpartum, which is supported by Zachut and
coworkers (2013). This reduction in insulin can contribute to the glucose sparing effect
characteristic of early lactation. This is demonstrated by the reduction in circulating glucose
observed postpartum, a response that can be exacerbated by reduced hepatic glucose synthesis
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due to lipid deposition (Piepenbrink and Overton, 2003b). Whereas we observed no effect of
adiposity on insulin concentration pre- or postpartum, Rico and colleagues (2015), observed that
overweight cows had higher circulating insulin concentrations than lean cows both pre- and
postpartum; however, their investigation did not include an evaluation of DMI which may
explain their insulin response (Drackley et al., 2005). Moreover, we found that adiposity did not
affect plasma glucose concentrations prepartum. Overfeeding dietary energy has been
demonstrated to increase circulating glucose during late gestation (Mann et al., 2016); however,
in our study DMI was comparable for lean and overweight cows; therefore, propionate supply
for hepatic gluconeogenesis was likely comparable.
We have previously observed that overweight cows have impaired systemic insulin
sensitivity during the transition from gestation to lactation as estimated using the revised
quantitative insulin sensitivity check index (RQUICKI; Holtenius and Holtenius, 2007; Rico et
al., 2015). However, we now contemplate the validity of using estimates of insulin sensitivity
since they rely heavily on FFA concentrations and have been demonstrated not to be correlated
with direct measurements of insulin sensitivity in periparturient dairy cows (Schoenberg et al.,
2012; Samii et al., 2015). Additionally, overconditioned ewes experienced a reduction on insulin
sensitivity as indicated by an HEC (Bergman et al., 1989). Therefore, we decided to use the gold
standard HEC approach for measuring insulin sensitivity and also determine if changes in
systemic insulin sensitivity are due to local changes in adipose tissue.
From the pre- to postpartum HEC, both groups experienced an increase in basal and SS
FFA. Furthermore, SS insulin was reduced. Other than elevated basal FFA and numerically
higher basal insulin postpartum, overweight cows displayed no differences in HEC blood
metabolite parameters. While GIR increased for both groups from pre- to postpartum due to
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increase glucose requirements for milk synthesis, we did not detect an effect of adiposity on
GIR. However, when accounting for changes in glucose and insulin, we demonstrated decreased
systemic insulin sensitivity in overweight cows postpartum using the SIClamp. We have previously
observed no effect of adiposity in response to an ITT or GTT (Samii et al., 2015). However,
Samii et al. (2015) did not measure circulating insulin during the tolerance tests and therefore
insulin maybe have been higher in overweight cows even though plasma glucose concentrations
remained stable. Furthermore, the doses of insulin and glucose given previously were
supraphysiological (insulin: 0.1 IU/kg BW; glucose: 0.3g/kg BW) and therefore may not be
practical for determining insulin sensitivity (Samii et al., 2015). Lastly, these tests were given in
the afternoon following morning feeding, whereas the HEC in the present study was performed
before feeding. In support of our findings, we have also observed that glucose-stimulated
reduction of plasma fatty acids following a GTT decreased from pre- to postpartum and was
lower for overweight cows (Samii et al., 2015; Rico et al., 2017). When considering
simultaneous changes in glucose and insulin, our work suggests that overweight cows experience
a reduction in systemic insulin sensitivity compared to lean cows.
In the present study the ratio of pAKT/tAKT decreased from pre- to postpartum as
expected. However, we were unable to detect an effect of adiposity or adiposity loss on
pAKT/tAKT pre- and postpartum. This result is consistent with the results of Mann and
coworkers (2016) in cows previously fed a high plane of nutrition during the dry period;
however, we note that their cows had markedly lower BFT measurements than the cows in our
study, and the difference between their treatment groups was not as dramatic. It has been
hypothesized that the reason overweight cows exhibit higher concentrations of FFA is either due
to specific changes in the lipolytic activity of adipose tissue or due to the greater amount of fat to
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mobilize (Rukkwamsuk et al., 1998; Herdt, 2000). While we did not observe any changes in
adipose tissue insulin signaling in overweight cows via AKT, Zachut and coworkers (2013)
measured AKT phosphorylation in SubqAT before and after a GTT and found decreased
pAKT/tAKT only in the cows who experienced high weight loss, suggesting adipose tissuespecific insulin resistance in these cows. DeKoster and coworkers (2016) observed that larger
adipocytes tend to be more resistant to the maximal antilipolytic effect of insulin. Therefore,
perhaps insulin signaling in adipose tissue could be affected via alternative mechanisms besides
AKT phosphorylation. For example, Choi and coworkers (2010) found that insulin regulates
adipocyte lipolysis through an AKT-independent, PI3K-dependent signaling pathway, which
leads to selective PKA phosphorylation of perilipin, while HSL activation remains AKTdependent. We also suggest that adipose tissue depots in distinct locations may respond
differently to changes during the periparturient period. For example, Locher and colleagues
(2011) suggest that retroperitoneal adipose tissue is more sensitive to periparturient changes in
HSL phosphorylation than SubqAT. In contrast to this hypothesis, De Koster and coworkers
(2016) found that independently of the location of the adipose tissue (Subq or omental), lipolytic
activity increased with adipocyte volume. Lastly, insulin-stimulated phosphorylation of AKT is
impaired in humans with insulin resistance and type 2 diabetes (Karlsson et al., 2005). We note
that it is possible that changes in systemic insulin sensitivity could be due to insulin antagonism
in skeletal muscle, rather than in adipose tissue of overweight dairy cows. Further research is
needed to investigate this possibility in dairy cows.
Conclusion
In the present study all cows experienced elevated FFA, liver lipid, and BHBA
concentrations during the transition from gestation to lactation, and these responses were more
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severe for overweight cows. While we did observe a decrease in SubqAT pAKT/tAKT indicating
reduced adipose-tissue specific insulin signaling postpartum, the elevations in FFA, liver lipid,
and BHBA in overweight cows were not due to changes in SubqAT AKT phosphorylation. More
severe systemic insulin resistance developed in overweight cows postpartum when accounting
for changes in insulin and glucose. This result is potentially due to numerically higher insulin
concentrations in overweight cows with no change in glucose concentrations. Further research is
needed to determine if overweight cows mobilize a greater amount of adipose tissue due to
specific changes in adipose tissue signaling leading to greater lipolysis or simply because of a
greater amount of adipose tissue mass. Additionally, future work should investigate insulin
sensitivity changes in different adipose depots, as well as skeletal muscle, and investigate AKTindependent pathways.

57

TABLES AND FIGURES
Table 4.1. Feed ingredients and composition (% of DM unless otherwise noted) for all cows
from 28 d before to 28 d after parturition.
Diet
Item
d -28 to parturition
Parturition to d 28
Ingredient
Corn silage
29.0
33.2
Mixed grass haylage
21.7
8.61
Mixed grass hay
25.0
1.95
Dry ground corn
2.72
20.8
Prepartum mix1
12.8
2
Lactation mix A
17.8
Aminoplus
5.82
5.72
Cottonseed with lint
4.35
Sugar cane syrup
3.40
Lactation mix B3
4.19
4
Close-up supplement
3.01
Nutrient composition
DM, %
51.3
51.7
NDF
47.9
31.1
ADF
30.5
19.8
CP
13.4
15.5
Crude Fat
3.30
4.80
Ash
8.30
7.90
NEL, Mcal/kg DM
1.43
1.70
1

Mix contained 27% commercial dry cow mix with Animate (Phibro Animal Health Corp., Teaneck, NJ),
17.3% ground corn, 17.3% crimped oats, 13% corn distillers, 12.9% soybean meal, 4.3% calcium
carbonate, 4.3% calcium sulfate, 2.6% Omnigen AF (Phibro Animal Health Corp.), 1.1 Monocalcium
phosphate, and < 1% of each of the following: Sel-plex 600 (Alltech Biotechnology, Nicholasville, KY)
and vitamin E.
2

Mix contained 33.6% citrus pulp, 19% soybean meal. 15.6% canola meal, 14% soybean hulls, 4.5%
calcium carbonate, 4.5% sodium bicarbonate, 2.8% urea, 2.7% fat, 2.4% sodium chloride, and <1% from
each of the following: Monocalcium phosphate, biotin, and Rumensin 90 (Elanco Animal Health,
Greenfield, IN).
3

Mix contained 43.6% Fermenten (Church and Dwight Co., Princeton, NJ), 21.8% calcium carbonate,
10.8% soybean hulls, 7.8% Mintrex blend (Novus International Inc., St. Charles, MO), 5.2% blood meal,
3.5% mag- nesium oxide, 2.6% Celmanax (Vi-COR, Mason City, IA), 2.6% Omnigen (Phibro Animal
Health Corp.), and <1% of each of the following: vitamin E, selenium selenite, and selenium yeast 600.
4

Mix contained 74.5% ground oats, 15.3% commercial amino acid, 8% Reashure (Balchem Encapsulates,
Slate Hill, NY), and <1% of each of the following: vitamin E and Niashure (Balchem Corporation, New
Hampton.
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Table 4.2. Metabolic responses to hyperinsulinemic-euglycemic clamp.
BCS1
Prepartum

P-value
Main Effects3

Postpartum

Item

Lean

Over

SEM2

Lean

Over

SEM

BCS

Stage

BCS at time of HEC
Basal FFA (mmol/L)
SS FFA (mmol/L)
Basal Glucose (mg/dL)
SS Glucose (mg/dL)
Basal Insulin (µU/mL)
SS Insulin (µU/mL)
GIR4 (mol/min/kg)
SIclamp5

2.97
715
182
63.4
66.2
7.72
42.8
11.8
0.15

3.92*
784
220
60.3
65.2
11.1
41.3
11.9
0.17

0.05
91.70
28.14
3.84
3.70
2.13
3.02
1.43
0.03

2.58
1020
319
57.9
63.4
3.71
22.6
21.4
0.51

3.33*
1300*
437
61.3
69.4
8.4
28.0
17.4*
0.26*

0.05
85.4
56.9
3.65
3.88
2.09
2.94
1.42
0.03

<0.01
0.10
0.11
0.98
0.54
0.13
0.52
0.18
<0.01

<0.01
<0.01
<0.01
0.53
0.84
0.04
<0.01
<0.01
<0.01

1

BCS ×
Stage
0.10
0.14
0.65
0.37
0.33
0.65
0.25
0.16
<0.01

Treatment were overweight cows during prepartum and postpartum.
SEM is the average between lean and overweight standard errors.
3
Main effects across prepartum and postpartum, d -10 and +12 respectively, during treatment. Data are presented as LS Means ± SEM. *P < 0.05,
Lean vs. Overweight.
4
Glucose infusion rate.
5
Insulin sensitivity index = (GIR / [SS Glucose × (SS Insulin – Basal Insulin)
2
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Figure 4.1. Effects of adiposity on body fat mass. (A) BCS, (B) BW, and (C) BFT records during
the transition from gestation to lactation; (D) changes in BCS, (E) BW, and (F) between d -21
and 28 d relative to parturition. Data are presented as least square means and their standard
errors. *P < 0.001.
Figure 4.2. Effects of adiposity on adipocyte histology. (A) Adipocyte volume and (B) adipocyte
count per 743.8 × 557.9 µm reading frame measured in SubqAT at 12 d before and 10 d after
parturition. Data are presented as least square means and their standard errors. *P < 0.001.
Figure 4.3. Effects of adiposity on dry matter intake (DMI). DMI between d -21 and d 28 relative
to parturition. Data are presented as least square means and their standard errors.
Figure 4.4. Effects of adiposity on milk production and composition. (A) Milk yield from d 0
until d 28 relative to parturition; (B) fat yield, (C) fat percent, (D) protein yield, (E) protein
percent, (F) lactose yield, and (E) lactose percent in milk on d 1, 3, 5, 7, 10, 12, 14, 21, and 28
relative to parturition. Data are presented as least square means and their standard errors.
Figure 4.5. Effects of adiposity on blood metabolites. (A) plasma glucose and (B) free fatty acid
(FFA) concentrations from d -21 to d 28 relative to parturition. Data are presented as least square
means and their standard errors.
Figure 4.6. Effects of adiposity on (A) liver lipid percentage and (B) plasma BHBA
concentrations from d -21 to d 28 relative to parturition. Data are presented as least square means
and their standard errors.
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Figure 4.7. Effects of adiposity on localized insulin signaling. Ratio of phosphorylated to total
protein kinase B (AKT) in (A) basal and (B) insulin-stimulated subcutaneous adipose tissue
explants (SubqAT) on d -12 and d 10 relative to parturition. Data are presented as least square
means and their standard errors.
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Figure 4.4
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Fig. 4.5
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Fig. 4.6
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Figure 4.7
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Chapter 5
GENERAL CONCLUSIONS
With the experiments presented in this thesis, we have evaluated the relationship between
free fatty acid supply, ceramide, and insulin sensitivity in dairy cows. We used a mass
spectrometry to quantify ceramide in serum and in the liver. We also determined that nutrient
restriction causes elevations in FFA, circulating ceramide, and hepatic ceramide and that long
chain ceramide is negatively associated with insulin sensitivity. Additionally, we used the goldstandard approach for directly measuring systemic insulin sensitivity in lean and overweight
cows and found that prepartum adiposity reduced systemic insulin sensitivity when taking into
account basal glucose and insulin concentrations. Contrary to our original hypothesis prepartum
adiposity did not impair localized insulin sensitivity via AKT-dependent mechanisms. Overall,
we show that elevations in FFA either through nutrient restriction or due to enhanced prepartum
adiposity and lipolysis can impair systemic insulin sensitivity. Our results suggest that ceramide
accrual represents a metabolic adaptation to nutrient restriction and impaired insulin action in
dairy cows.
Future research should determine the compartmental origin of circulating ceramide,
demonstrate that ceramides are a causal inhibitor of insulin action, develop novel nutritional
interventions to prevent ceramide accumulation, and determine the efficacy of using 24:0ceramide as a biomarker for metabolic disease. Coming work should also consider whether the
cause of elevated circulating FFA in overweight cows is due to specific changes in signaling in
distinct adipose tissue depots or due to greater fat mass to mobilize. Collectively, these
approaches have the potential to delineate the coordinated shift in metabolism that occurs during
the periparturient period in order to improve dairy cow health.
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